PL350941A1 - Pyrazole-3-on-derivative as factor xa inhibitors - Google Patents

Pyrazole-3-on-derivative as factor xa inhibitors

Info

Publication number
PL350941A1
PL350941A1 PL00350941A PL35094100A PL350941A1 PL 350941 A1 PL350941 A1 PL 350941A1 PL 00350941 A PL00350941 A PL 00350941A PL 35094100 A PL35094100 A PL 35094100A PL 350941 A1 PL350941 A1 PL 350941A1
Authority
PL
Poland
Prior art keywords
pyrazole
inhibitors
derivative
factor
Prior art date
Application number
PL00350941A
Other languages
English (en)
Inventor
Dieter Dorsch
Horst Juraszyk
Werner Mederski
Christos Tsaklakidis
Hanns Wurziger
Sabine Bernotat-Danielowski
Guido Melzer
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL350941A1 publication Critical patent/PL350941A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D231/08—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL00350941A 1999-03-03 2000-02-29 Pyrazole-3-on-derivative as factor xa inhibitors PL350941A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19909237A DE19909237A1 (de) 1999-03-03 1999-03-03 Pyrazol-3-on-derivate

Publications (1)

Publication Number Publication Date
PL350941A1 true PL350941A1 (en) 2003-02-24

Family

ID=7899522

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00350941A PL350941A1 (en) 1999-03-03 2000-02-29 Pyrazole-3-on-derivative as factor xa inhibitors

Country Status (17)

Country Link
EP (1) EP1157010A1 (xx)
JP (1) JP2002538143A (xx)
KR (1) KR20010102428A (xx)
CN (1) CN1342148A (xx)
AU (1) AU2916500A (xx)
BR (1) BR0008608A (xx)
CA (1) CA2364908A1 (xx)
CZ (1) CZ20013164A3 (xx)
DE (1) DE19909237A1 (xx)
HU (1) HUP0200242A3 (xx)
MX (1) MXPA01008844A (xx)
NO (1) NO20014234L (xx)
PL (1) PL350941A1 (xx)
RU (1) RU2001126566A (xx)
SK (1) SK12152001A3 (xx)
WO (1) WO2000051989A1 (xx)
ZA (1) ZA200108064B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455525B1 (en) 1999-11-04 2002-09-24 Cephalon, Inc. Heterocyclic substituted pyrazolones
HUE025683T2 (hu) 2002-12-03 2016-04-28 Pharmacyclics Llc VIIA faktor inhibitor 2-(2-hidroxi-bifenil-3-il)-1H-benzoimidazol-5-karboxamidin-származékok
JPWO2005012255A1 (ja) * 2003-08-01 2006-09-14 三菱ウェルファーマ株式会社 炎症性関節疾患の治療剤
DE102008020113A1 (de) 2008-04-23 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Substituierte Dihydropyrazolone und ihre Verwendung
DE102005019712A1 (de) 2005-04-28 2006-11-09 Bayer Healthcare Ag Dipyridyl-dihydropyrazolone und ihre Verwendung
DE102006050516A1 (de) 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dihydropyrazolone und ihre Verwendung
DE102006050513A1 (de) 2006-10-26 2008-04-30 Bayer Healthcare Ag Substitiuierte Dihydropyrazolone und ihre Verwendung
DE102006050515A1 (de) 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dipyridiyl-dihydropyrazolone und ihre Verwendung
DE102007044032A1 (de) 2007-09-14 2009-03-19 Bayer Healthcare Ag Substituierte heterocyclische Verbindungen und ihre Verwendung
DE102007048447A1 (de) 2007-10-10 2009-04-16 Bayer Healthcare Ag Substituierte Dihydropyrazolthione und ihre Verwendung
DE102010044131A1 (de) 2010-11-18 2012-05-24 Bayer Schering Pharma Aktiengesellschaft Substituiertes Natrium-1H-pyrazol-5-olat

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612353A (en) * 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
JP3994453B2 (ja) * 1995-10-13 2007-10-17 日産化学工業株式会社 ピラゾロン類

Also Published As

Publication number Publication date
WO2000051989A1 (de) 2000-09-08
NO20014234L (no) 2001-10-24
SK12152001A3 (sk) 2002-03-05
AU2916500A (en) 2000-09-21
JP2002538143A (ja) 2002-11-12
HUP0200242A2 (hu) 2002-11-28
HUP0200242A3 (en) 2002-12-28
CA2364908A1 (en) 2000-09-08
CZ20013164A3 (cs) 2001-12-12
NO20014234D0 (no) 2001-08-31
BR0008608A (pt) 2002-01-02
MXPA01008844A (es) 2002-05-14
KR20010102428A (ko) 2001-11-15
CN1342148A (zh) 2002-03-27
ZA200108064B (en) 2003-01-02
EP1157010A1 (de) 2001-11-28
DE19909237A1 (de) 2000-09-07
RU2001126566A (ru) 2004-02-27

Similar Documents

Publication Publication Date Title
ZA200306490B (en) Inhibitors of factor Xa.
AU2002350217A8 (en) Glycinamides as factor xa inhibitors
HK1070352A1 (en) Indole-2-carboxamides as factor xa inhibitors
IL137517A0 (en) Substituted oxoazaheterocyclyl factor xa inhibitors
AU2001273040A1 (en) Factor xa inhibitors
GB9900416D0 (en) Inhibitors
AU6762400A (en) Inhibitors of factor xa
AU5723500A (en) Inhibitors of factor xa
AU5283700A (en) Inhibitors of factor xa
AU5283900A (en) Inhibitors of factor xa
AU3857300A (en) Inhibitors of factor xa
AU5284000A (en) Inhibitors of factor xa
AU9550701A (en) Novel compounds inhibiting factor xa activity
IL162454A0 (en) Pyrrolidine-2-ones as factor xa inhibitors
IL159195A0 (en) Pyrrolidine derivatives as factor xa inhibitors
PL350941A1 (en) Pyrazole-3-on-derivative as factor xa inhibitors
HUP0201451A3 (en) Factor viia inhibitors
EP1153022A4 (en) PROTEASE INHIBITORS
GB2389113B (en) B-secretase inhibitor
GB9929341D0 (en) Inhibitors
GB9929340D0 (en) Inhibitors
GB9917294D0 (en) Inhibitors
GB9900413D0 (en) Inhibitors